Heart disease effort a focus in appeal push

This year’s Heart Foundation Christmas Appeal highlights the value of research into fighting heart disease, including heart attack.

According to National Heart Foundation Group CEO Adjunct Professor John Kelly, research is key to finding treatment.

“A fine example is the work being done by Heart Foundation Vanguard grant recipient, Professor Kaz Negishi, who is investigating a new technique to improve the emergency response to a heart attack,” he said.

“Professor Negishi’s research could eventually lead to more people … surviving a heart attack. It could prove particularly important for rural and regional Australians.”

The work being undertaken by Professor Negishi includes setting up clinical trials to determine if a new technique will make fibrinolysis – the method where drugs are injected to dissolve blood clots, and typically used in patients who can’t access a centre for stent therapy – work better.

Over the past 60 years research funded by the Heart Foundation has helped make significant advances in the prevention, diagnosis and treatment of heart disease.

This includes the invention of the pacemaker, the setting up of coronary units, improved cardiac rehab, and effective treatments for high blood pressure and cholesterol.

To donate to the Heart Foundation Christmas Appeal to help fund vital research, visit: heartfoundation.org.au/christmas-appeal

Must Read

Professor Kevin Batty elected as President of the Council of Pharmacy...

The Australia Pharmacy Council (APC) welcomes the election of Professor Kevin Batty as President of the Council of Pharmacy Schools: Australia and New Zealand...